Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Combining genetic models helps improve heat tolerance in beef cattle.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Lipids may help treat hair loss by promoting hair growth through the HIF-1 pathway.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

STK11 gene polymorphism does not predict metformin response in PCOS.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Some blood pressure medications are linked to a higher risk of skin cancer.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Keratins are crucial for cell structure, growth, and disease risk.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Altering SSAT affects fat metabolism and body fat in mice.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Antiandrogen therapy helps treat genetic hair loss.

Dermal papilla cell vesicles can boost hair growth genes in fat stem cells.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.